BTK-IN-14 structure
|
Common Name | BTK-IN-14 | ||
|---|---|---|---|---|
| CAS Number | 2764674-60-2 | Molecular Weight | 676.81 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C38H44N8O4 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of BTK-IN-14BTK-IN-14 is a potent inhibitor of BTK. BTK plays an important role in signaling mediated by B cell antigen receptor (BCR) and Fcγreceptor (FcγR) in B cells and myeloid cells, respectively. BTK-IN-14 has the potential for the research of related diseases, especially autoimmune diseases, inflammatory diseases or cancer (extracted from patent WO2022057894A1, compound 1)[1]. |
| Name | BTK-IN-14 |
|---|
| Description | BTK-IN-14 is a potent inhibitor of BTK. BTK plays an important role in signaling mediated by B cell antigen receptor (BCR) and Fcγreceptor (FcγR) in B cells and myeloid cells, respectively. BTK-IN-14 has the potential for the research of related diseases, especially autoimmune diseases, inflammatory diseases or cancer (extracted from patent WO2022057894A1, compound 1)[1]. |
|---|---|
| Related Catalog | |
| References |
[1]. Guangxiu Dai, et al. Heteroaryl heterocyclic compounds and uses thereof. Patent WO2022057894A1. |
| Molecular Formula | C38H44N8O4 |
|---|---|
| Molecular Weight | 676.81 |